Spiriva (Boehringer Ingelheim Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Spiriva drug offered from Boehringer Ingelheim Pharmaceuticals Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | TIOTROPIUM BROMIDE |
SUBSTANCE NAME: | TIOTROPIUM BROMIDE MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | ORAL; RESPIRATORY (INHALATION) |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-10-11 |
END MARKETING DATE: | 0000-00-00 |
Spiriva HUMAN PRESCRIPTION DRUG Details:
Item Description | Spiriva from Boehringer Ingelheim Pharmaceuticals Inc. |
LABELER NAME: | Boehringer Ingelheim Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 18(ug/1) |
START MARKETING DATE: | 2005-10-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0597-0075_f04140bc-0901-9ca2-0cb7-3e774c8afca1 |
PRODUCT NDC: | 0597-0075 |
APPLICATION NUMBER: | NDA021395 |
Other TIOTROPIUM BROMIDE MONOHYDRATE Pharmaceutical Manufacturers / Labelers: